Basic Information
Spexis is a clinical-stage biopharmaceutical company headquartered in Switzerland, focusing on rare diseases and oncology. Its mission is to discover and develop innovative drugs to help patients in need of novel transformative treatments.
Spexis, Ltd.
CantonofBasel-City,Switzerland
15~50 people
January 01, 1996
info@spexisbio.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios